Application 209355
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BRYHALI | HALOBETASOL PROPIONATE | LOTION;TOPICAL | 0.01% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-0002 | Bryhali | halobetasol propionate | Bausch Health US, LLC | NDA | Current |
| 0187-0002 | Bryhali | halobetasol propionate | Bausch Health Americas Inc. | NDA | Current |
| 0187-0002 | Bryhali | halobetasol propionate | Valeant Pharmaceuticals North America LLC | NDA | Current |
| 0187-0002 | Bryhali | halobetasol propionate | Bausch Health US, LLC | NDA | Current |